Abstract
The pathobiology of CF lung disease has yet to be fully elucidated and several theories have been proposed in recent years relating the basic biochemical defect caused by CFTR dysfunction to the CF phenotype. Within the last decade accumulating evidence has suggested that the pulmonary inflammation observed in CF patients may be intrinsically related to the CFTR mutation, resulting in an augmented inflammatory response. This review discusses our changing understanding of the link between CFTR dysfunction and CF lung disease, focusing especially on the role of hyperinflammatory processes. A better understanding of these mechanisms will lead to better treatments for CF and other suppurative lung diseases.
Keywords: Cystic fibrosis, inflammation, CFTR, Pseudomonas aeruginosa
Current Respiratory Medicine Reviews
Title: Inflammation, Hyperinflammation & Cystic Fibrosis Lung Disease – A Paradigm Shift?
Volume: 5 Issue: 3
Author(s): Emmet H. Major and J. Stuart Elborn
Affiliation:
Keywords: Cystic fibrosis, inflammation, CFTR, Pseudomonas aeruginosa
Abstract: The pathobiology of CF lung disease has yet to be fully elucidated and several theories have been proposed in recent years relating the basic biochemical defect caused by CFTR dysfunction to the CF phenotype. Within the last decade accumulating evidence has suggested that the pulmonary inflammation observed in CF patients may be intrinsically related to the CFTR mutation, resulting in an augmented inflammatory response. This review discusses our changing understanding of the link between CFTR dysfunction and CF lung disease, focusing especially on the role of hyperinflammatory processes. A better understanding of these mechanisms will lead to better treatments for CF and other suppurative lung diseases.
Export Options
About this article
Cite this article as:
Major H. Emmet and Elborn Stuart J., Inflammation, Hyperinflammation & Cystic Fibrosis Lung Disease – A Paradigm Shift?, Current Respiratory Medicine Reviews 2009; 5 (3) . https://dx.doi.org/10.2174/157339809788922388
DOI https://dx.doi.org/10.2174/157339809788922388 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Prognostic and Predictive Molecular Markers in Cutaneous Malignant Melanoma: The First Step Toward Personalized Medicine
Current Pharmacogenomics and Personalized Medicine Modulating Poly (ADP-Ribose) Polymerase Activity: Potential for the Prevention and Therapy of Pathogenic Situations Involving DNA Damage and Oxidative Stress
Current Pharmaceutical Biotechnology Roles of Retinoic Acid in Induction of Immunity and Immune Tolerance
Endocrine, Metabolic & Immune Disorders - Drug Targets Rationalizing the Study of Plants for the Treatment of Oral Pain
Current Chemical Biology Xanthine Oxidoreductase in Drug Metabolism: Beyond a Role as a Detoxifying Enzyme
Current Medicinal Chemistry The Use of PET for Radiotherapy
Current Medical Imaging New Insights in Drug-Induced Mitochondrial Toxicity
Current Pharmaceutical Design Meet Our Editorial Board Member
Current Computer-Aided Drug Design Eicosanoids in Prevention and Management of Diseases
Current Molecular Medicine Dihydrofolate Reductase as a Target for Chemotherapy in Parasites
Current Pharmaceutical Design The Role of the Gastrointestinal Microbiota in Colorectal Cancer
Current Pharmaceutical Design Recent Aspects of Osmotic Pump Systems: Functionalization, Clinical use and Advanced Imaging Technology
Current Drug Metabolism Drug Repurposing Approaches: Existing Leads for Novel Threats and Drug Targets
Current Protein & Peptide Science The Conduct of Drug Metabolism Studies Considered Good Practice (I): Analytical Systems and In Vivo Studies
Current Drug Metabolism Cratylia mollis Lectin: A Versatile Tool for Biomedical Studies
Current Bioactive Compounds Selection Criteria for Probiotics and Potential of Cereal Based Food Products as Novel Probiotic-Carriers
Current Nutrition & Food Science Therapeutic Options for the Management of Aromatase Inhibitor- Associated Bone Loss
Endocrine, Metabolic & Immune Disorders - Drug Targets Editorial [Hot Topic :Current Advances In Therapeutic Applications of Nuclear Receptors (Guest Editor: Stefano Fiorucci)]
Current Topics in Medicinal Chemistry Toxicity and Tolerability of <sup>177</sup>Lu-DOTA-TATE PRRT with a Modified Administered Activity Protocol in NETs of Variable Origin – A Phase 2 Registry Study
Current Radiopharmaceuticals Curcumin: A Dietary Phytochemical for Targeting the Phenotype and Function of Dendritic Cells
Current Medicinal Chemistry